Chronotherapy for Radiotherapy of Glioma
NCT04735939 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2021-02-03
Summary
This study aims to determine if there is any difference in the efficacy of radiotherapy for glioma outcomes in the morning or in the evening. The study team believes that there may be a benefit to taking the radiotherapy at a certain time of day. To test this theory the study asks participants who are already taking radiotherapy for glioma consistently at either the morning or in the evening based on when they currently take their radiotherapy. There will be this study visits where the participant will be asked to fill in questionnaires related to their neurological symptoms, their sleep habits, sleep quality, survival situation, and general health information followed by a blood draw.
Conditions
- To Determine Whether the Timing of Radiotherapy Has an Effect on Patient Outcomes
Interventions
- RADIATION
-
radiotherapy
Determine whether there is a difference in outcomes seen when patients are assigned to take their radiotherapy at either a morning time or evening time.
Sponsors & Collaborators
-
General Hospital of Ningxia Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- China
Study Locations
More Related Trials
-
Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00006353 ·Status: COMPLETED ·Phase: PHASE3
-
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
NCT04479696 ·Status: RECRUITING ·Phase: NA
-
Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma
NCT04856852 ·Status: UNKNOWN ·Phase: NA
-
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
NCT00004259 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Hypofractionated Radiation Therapy for Glioblastoma
NCT02206230 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
NCT02590263 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial
NCT03082846 ·Status: COMPLETED ·Phase: NA
-
Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma
NCT02887040 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
NCT00978458 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00390403 ·Status: COMPLETED ·Phase: PHASE1
-
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
NCT00042991 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas
NCT04244708 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
NCT00006388 ·Status: COMPLETED ·Phase: PHASE2
-
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
NCT00114140 ·Status: COMPLETED ·Phase: PHASE2
-
GM1 Prophylaxis for WBRT Related Cognitive Dysfunction
NCT04395339 ·Status: TERMINATED ·Phase: PHASE3
-
Radiation Therapy in Treating Patients With Glioblastoma
NCT00019058 ·Status: COMPLETED ·Phase: PHASE1
-
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
NCT06344130 ·Status: RECRUITING ·Phase: PHASE1
-
Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas
NCT05393258 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain Metastases
NCT02832635 ·Status: UNKNOWN ·Phase: PHASE2
-
Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
NCT04397679 ·Status: TERMINATED ·Phase: PHASE1
-
Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma.
NCT04536649 ·Status: UNKNOWN ·Phase: PHASE3
-
Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme
NCT00820963 ·Status: COMPLETED ·Phase: PHASE3
-
Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma
NCT00017264 ·Status: COMPLETED ·Phase: PHASE1
-
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
NCT01062425 ·Status: COMPLETED ·Phase: PHASE2
-
Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine
NCT00074607 ·Status: TERMINATED ·Phase: PHASE1